Immune system signaling pathways

Immune system signaling pathways represent the integrated network of molecular interactions that govern the detection of threats and the subsequent coordination of the immune response. These pathways involve a diverse array of cell-surface receptors, such as Toll-like receptors and T-cell receptors, which trigger intracellular cascades including the JAK/STAT, NF-κB, and MAPK pathways (Source: KEGG Pathway Database). Proper signaling is essential for maintaining self-tolerance and eliminating pathogens; however, aberrant signaling is a primary driver of autoimmune diseases, chronic inflammation, and the progression of various cancers (Source: Nature Reviews Immunology). Pharmacological targeting of these pathways is a cornerstone of modern medicine, utilizing biologics like monoclonal antibodies to neutralize cytokines or small molecules to inhibit specific kinases (Source: StatPearls). While highly effective, modulating these broad pathways carries significant risks, including increased susceptibility to infection and potential for off-target inflammatory responses (Source: Journal of Clinical Investigation). Because these pathways are often pleiotropic and interconnected, targeting them requires precision to avoid systemic toxicity or profound immunosuppression (Source: PubMed Central).

Other names

Immune signalingImmunological signaling cascadesLeukocyte signaling pathways

Modulation of intracellular and extracellular signaling cascades, including kinase inhibition, receptor antagonism, or checkpoint blockade, to alter immune cell behavior.